Results 31 to 40 of about 277,119 (298)

GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis

open access: yesHepatology, 2021
Most patients with HCC are diagnosed at a late stage, highlighting the need for more accurate surveillance tests. Although biomarkers for HCC early detection have promising data in Phase 2 case–control studies, evaluation in cohort studies is critical ...
A. Singal   +8 more
semanticscholar   +1 more source

Intratumor heterogeneity in HCC

open access: yesAging, 2015
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide [1], generally arising on the background of chronic liver diseases such as chronic viral hepatitis, alcohol-induced liver injury, or fatty liver disease. So far, classification proposals for HCC based on molecular markers are not yet routinely applied in ...
Friemel, Juliane   +2 more
openaire   +5 more sources

Diabetes medications and risk of HCC

open access: yesHepatology, 2022
Type 2 diabetes mellitus is a recognized risk factor for HCC in patients with liver disease, independent from the etiology of their liver disease. Hence, prevention and treatment of type 2 diabetes mellitus and its underlying cause, insulin resistance ...
M. C. Plaz Torres   +5 more
semanticscholar   +1 more source

Localized Metastatic Recurrence of HCC following Distal Extremity Trauma: Bone Scintigraphy and Anatomicopathological Correlation

open access: yesWorld Journal of Nuclear Medicine, 2022
Hepatocellular carcinoma (HCC) is the most common type of liver cancer, with a poor median survival when left untreated. Extrahepatic metastases involving musculoskeletal tissues typically present with concomitant nonosseous metastases at the time of ...
Edgar Zamora   +3 more
doaj   +1 more source

The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications

open access: yesFrontiers in Immunology, 2022
Hepatocellular carcinoma (HCC) remains an important complication of chronic liver disease, especially when cirrhosis occurs. Existing treatment strategies include surgery, loco-regional techniques, and chemotherapy.
M. Sajid, Lianxin Liu, Cheng-song Sun
semanticscholar   +1 more source

Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges

open access: yesFrontiers in Cell and Developmental Biology, 2021
Immune associated cells in the microenvironment have a significant impact on the development and progression of hepatocellular carcinoma (HCC) and have received more and more attention.
Xiaopei Hao   +7 more
semanticscholar   +1 more source

Maximum principles for parabolic systems coupled in both first-order and zero-order terms

open access: yesInternational Journal of Mathematics and Mathematical Sciences, 1994
Some generalized maximum principles are established for linear second-order parabolic systems in which both first-order and zero-order terms are coupled.
Chiping Zhou
doaj   +1 more source

Phosphorus magnetic resonance spectroscopy in diagnosis of focal liver lesions

open access: yesУчёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, 2013
31PMR spectroscopy was carried out in 93 patients with various focal lesions in the liver and in the control group people. The method was proved to be noninvasive and highly informative in studying of biochemical processes in the liver on the cell level ...
S. S. Bagnenko, G. E. Trufanov
doaj   +1 more source

ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM

open access: yesTheranostics, 2021
Metabolic reprogramming, especially Warburg effect, is a key event in tumor initiation and progression. ZEB1 plays a vital role in metastasis of various cancers.
Yanming Zhou   +15 more
semanticscholar   +1 more source

Immune Checkpoint Inhibitors in the Treatment of HCC

open access: yesFrontiers in Oncology, 2021
Hepatocellular carcinoma (HCC) is the typical inflammation-induced neoplasia. It often prospers where a chronic liver disease persists, thus leading a strong rationale for immune therapy.
C. Donisi   +13 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy